Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 09/20/2002
Publisher: CLSI
File Format: PDF
$120.00$240.61
Published:20/09/2002
Pages:56
CLSI EP09-A2 addresses procedures for determining the bias between two clinical methods or devices, and for the design of a method comparison experiment using split patient samples and data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guidleine for use in satisfying a regulatory requirement.
Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline, MM03-A2
$142.00 $285.63
Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods; Approved Guideline, MM13AE
$90.00 $180.00
A Model for Managing Medical Device Alerts (Hazards and Recalls) for Healthcare Organizations; Approved Guideline, QMS10AE
$117.00 $234.45
Quality Control MIC Limits for Mycobacterium peregrinum and Staphylococcus aureus (When Testing Rapidly Growing Mycobacteria); Informational Supplement, M24-S1
$109.00 $218.46
